MX2015009524A - Beta-criptoxantina de fuente de planta de proceso para su preparacion. - Google Patents

Beta-criptoxantina de fuente de planta de proceso para su preparacion.

Info

Publication number
MX2015009524A
MX2015009524A MX2015009524A MX2015009524A MX2015009524A MX 2015009524 A MX2015009524 A MX 2015009524A MX 2015009524 A MX2015009524 A MX 2015009524A MX 2015009524 A MX2015009524 A MX 2015009524A MX 2015009524 A MX2015009524 A MX 2015009524A
Authority
MX
Mexico
Prior art keywords
beta
cryptoxanthin
preparation
plant source
trans
Prior art date
Application number
MX2015009524A
Other languages
English (en)
Inventor
Sunilkumar Thattaruparambil Krishna Das
Shankaranayana Madapura Lingappiah
Sherena Padinjarevattom Abdulkadir
Shankaranarayanan Jeyakodi
Original Assignee
Omniactive Health Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omniactive Health Technologies Ltd filed Critical Omniactive Health Technologies Ltd
Publication of MX2015009524A publication Critical patent/MX2015009524A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/24—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by six-membered non-aromatic rings, e.g. beta-carotene
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/02—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains containing only carbon and hydrogen atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/40—Colouring or decolouring of foods
    • A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
    • A23L5/43—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
    • A23L5/44—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • B01D15/426—Specific type of solvent
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B61/00—Dyes of natural origin prepared from natural sources, e.g. vegetable sources
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Analytical Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)

Abstract

La presente invención provee cristales de betacriptoxantina a partir de fuente de planta y un proceso para su preparación. La presente invención es concerniente en particular con un proceso para la preparación de cristales de beta-criptoxantina de alta pureza que comprenden por lo menos alrededor de 10% en peso de xantófilos totales, de los cuales por lo menos alrededor de 75% en peso consiste de trans-beta criptoxantina y el resto incluye beta-caroteno y cantidades en trazas de trans-capsantina y otros carotenoides derivados de la fuente de planta, inclusive frutas de pimiento. La producción de cristales de beta-criptoxantina con alto contenido de trans-beta-criptoxantina la hace ideal y apropiada para uso como material fuente de provitamina A y también tiene efectos potenciales para mejorar la salud del hueso e inhibir la resorción del hueso.
MX2015009524A 2013-01-24 2014-01-23 Beta-criptoxantina de fuente de planta de proceso para su preparacion. MX2015009524A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN214MU2013 2013-01-24
PCT/IB2014/000478 WO2014115037A2 (en) 2013-01-24 2014-01-23 Beta-cryptoxanthin from plant source and a process for its preparation

Publications (1)

Publication Number Publication Date
MX2015009524A true MX2015009524A (es) 2016-04-25

Family

ID=54196703

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015009524A MX2015009524A (es) 2013-01-24 2014-01-23 Beta-criptoxantina de fuente de planta de proceso para su preparacion.

Country Status (12)

Country Link
US (2) US9771323B2 (es)
EP (1) EP2948428A2 (es)
JP (1) JP2016505066A (es)
KR (1) KR20150129680A (es)
CN (1) CN105073711A (es)
CA (1) CA2898890A1 (es)
HK (1) HK1212967A1 (es)
IL (1) IL240083A0 (es)
MX (1) MX2015009524A (es)
PH (1) PH12015501630A1 (es)
SG (1) SG11201505759RA (es)
WO (1) WO2014115037A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3285295A (en) * 1965-06-14 1966-11-15 St Regis Paper Co Method and apparatus for filling containers with powdered or granular materials
US10568846B2 (en) * 2015-04-27 2020-02-25 Omniactive Health Technologies Limited Betacryptoxanthin compositions, processes for preparation and uses thereof
KR101722924B1 (ko) * 2016-12-28 2017-04-05 이경화학 주식회사 고순도 mct 오일을 함유하는 피부각전 제거용 화장료 조성물의 제조방법 및 그에 의해 제조된 화장료 조성물
CN106977440B (zh) * 2017-04-17 2019-01-11 云南宏绿辣素有限公司 一种分离纯化β-隐黄质的方法
EP3866616A4 (en) * 2018-11-29 2022-04-20 Sevanti Mehta MANUFACTURE OF CAROTENOID COMPOSITIONS
WO2022018162A1 (en) 2020-07-22 2022-01-27 Dsm Ip Assets B.V. FORMULATIONS OF NEW β-CRYPTOXANTHIN CRYSTAL FORM, PROCESSES FOR THEIR MANUFACTURE AND THEIR USES
WO2022018161A1 (en) 2020-07-22 2022-01-27 Dsm Ip Assets B.V. Beta-cryptoxanthin crystal forms, liquid formulations thereof and processes for their manufacture
WO2024102237A1 (en) * 2022-11-11 2024-05-16 Kemin Industries, Inc. Process for isolation of capsanthin and other carotenoids from paprika oleoresin

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3944532B2 (ja) 1998-10-30 2007-07-11 独立行政法人農業・食品産業技術総合研究機構 高純度β−クリプトキサンチンの製造方法
WO2002060865A1 (en) 2001-01-30 2002-08-08 Sabinsa Corporation Process of obtaining high purity of zeaxanthin, cryptoxanthin & other carotenoids from byadagi chili/chappatta chili & carotenoid composition
JP4834290B2 (ja) 2002-02-06 2011-12-14 ユニバーシティ オブ メリーランド カレッジ パーク 市販のルテインからのβ−クリプトキサンチンおよびα−クリプトキサンチンの製造方法
US20060121557A1 (en) 2002-09-27 2006-06-08 Tatsuo Hoshino Production of zeaxanthin by phaffia
US8148431B2 (en) 2002-10-25 2012-04-03 Kemin Health, L.C. Osteogenesis promoter containing β-cryptoxanthin as the active ingredient
CN1953669B (zh) 2004-05-18 2010-06-16 帝斯曼知识产权资产管理有限公司 β-隐黄质的用途
EP1825858A4 (en) 2004-11-16 2008-03-12 Masayoshi Yamaguchi COMPOSITION FOR PROMOTING OSTEOGENESIS AND INCREASING THE BONE MINIMAL CONTENT
JP3969458B2 (ja) 2005-04-21 2007-09-05 株式会社村田製作所 セラミック基板の製造方法およびセラミック基板
JP2007112744A (ja) 2005-10-20 2007-05-10 Toyo Seikan Kaisha Ltd β−クリプトキサンチン成分含有抽出物液およびこの抽出物液を添加してなる飲食物および石鹸または化粧品
US20070116818A1 (en) 2005-11-22 2007-05-24 Toyo Seikan Kaisha, Ltd. Extract containing beta-cryptoxanthin component from persimmon fruit
EP2047760A4 (en) 2006-07-28 2012-07-04 Unitika Ltd ORAL COMPOSITION FOR INCREASED ABSORPTION OF CRYPTOXANTHINE
US20080124755A1 (en) 2006-10-12 2008-05-29 Michael Tai-Man Louie Biosynthesis of beta-cryptoxanthin in microbial hosts using an Arabidopsis thaliana beta-carotene hydroxylase gene
US8021698B2 (en) 2006-12-20 2011-09-20 Kemin Foods, L.C. Method of improving cardiovascular health
US20090093015A1 (en) 2007-10-09 2009-04-09 Kemin Foods, L.C. Beta-cryptoxanthin production using a novel lycopene beta-monocyclase gene
US8222458B2 (en) 2008-06-13 2012-07-17 University Of Maryland, College Park Process or synthesis of (3S)- and (3R)-3-hydroxy-beta-ionone, and their transformation to zeaxanthin and beta-cryptoxanthin
CN102219721B (zh) 2011-04-02 2013-08-07 秦皇岛大惠生物技术有限公司 一种含有β-隐黄质的浓缩物的提取方法与采用该方法所得到的浓缩物及其用途

Also Published As

Publication number Publication date
JP2016505066A (ja) 2016-02-18
SG11201505759RA (en) 2015-08-28
WO2014115037A3 (en) 2014-12-31
EP2948428A2 (en) 2015-12-02
WO2014115037A2 (en) 2014-07-31
KR20150129680A (ko) 2015-11-20
PH12015501630A1 (en) 2015-10-12
CA2898890A1 (en) 2014-07-31
US20170334845A1 (en) 2017-11-23
IL240083A0 (en) 2015-09-24
US10301259B2 (en) 2019-05-28
US20150361040A1 (en) 2015-12-17
CN105073711A (zh) 2015-11-18
HK1212967A1 (zh) 2016-06-24
US9771323B2 (en) 2017-09-26

Similar Documents

Publication Publication Date Title
PH12015501630A1 (en) Beta-cryptoxanthin from plant source and a process for its preparation
JOP20210064A1 (ar) عملية لتحضير 5- فلورو-1h- بيرازولوبيريدينات مستبدلة
MX2016004946A (es) Procesos para la preparacion de compuestos plaguicidas.
MX2016004942A (es) Procesos para la preparacion de compuestos plaguicidas.
MX2016004943A (es) Procesos para la preparacion de compuestos plaguicidas.
CR20130200A (es) Composiciones que contienen derivados de antraquinona como promotores de crecimiento y agentes antifúngicos
IN2014DN08254A (es)
BR112014013098A2 (pt) composições compreendendo ácidos graxos que têm 20 carbonos e métodos de produção e uso dos mesmos
MX2016004533A (es) Derivados de n-cicloalquil-n-(biheterociclilmetilen)-(tio)carboxam ida.
MX359069B (es) Sal y formas cristalinas de inhibidor de quinasa tipo polo-4.
MX2022004935A (es) (+)- trans tetrahidrocannabinol ((+)-trans-thc) para uso como medicamento.
MX2015010819A (es) Compuestos reguladores del crecimiento vegetal.
MX2016012851A (es) Un metodo para producir 1,1,2,3-tetracloropropeno con alto rendimiento.
EA201690692A1 (ru) Пищевая липидная композиция, содержащая стеаридоновую кислоту и оливковое масло
UY35302A (es) Compuestos reguladores del crecimiento vegetal, proceso de preparación, composiciones de los mismos usos y métodos de empleo
MX2015010961A (es) Croman-6-iloxi-cicloalcanos sustituidos y su uso como productos farmaceuticos.
ES2531286A1 (es) Composiciones antioxidantes de un producto obtenido del fruto de camu camu
WO2011089525A3 (en) Chia seed protein concentrate
NZ706070A (en) Crystalline phase of (3s.3s’) 4,4’-disulfanediylbis(3-aminobutane 1 -sulfonic acid) with l-lysine
WO2015004687A3 (en) Novel tricyclic compounds and process for preparation thereof
MX2013010001A (es) Derivados de androstanediol como compuestos reguladores del crecimiento de las plantas.
MX2018016394A (es) Proceso para la obtencion de acido metacrilico de alta pureza a partir de una corriente de acido metacrilico bruto.
TH153747A (th) สารประกอบควบคุมการเจริญเติบโตของพืช
IN2013MU03140A (es)
UA72595U (ru) Способ приготовления диетической добавки с антибактериальным действием